|
🐜
|
Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology
9 auth.
A. Flotats,
I. Carrió,
D. Agostini,
D. Le Guludec,
C. Marcassa,
M. Schaffers,
...
G. Somsen,
M. Unlu,
H. Verberne
|
8 |
2010 |
8
🐜
|
|
🐜
|
Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis
10 auth.
F. Rouzet,
R. Chequer,
K. Benali,
L. Lepage,
W. Ghodbane,
X. Duval,
...
B. Iung,
A. Vahanian,
D. Le Guludec,
F. Hyafil
|
7 |
2014 |
7
🐜
|
|
🐢
|
Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases.
10 auth.
L. Sarda,
A. Crémieux,
Y. Lebellec,
A. Meulemans,
R. Lebtahi,
G. Hayem,
...
R. Génin,
N. Delahaye,
D. Huten,
D. Le Guludec
|
7 |
2003 |
7
🐢
|
|
🐜
|
Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison.
9 auth.
G. Cadiot,
R. Lebtahi,
L. Sarda,
G. Bonnaud,
J. Marmuse,
C. Vissuzaine,
...
P. Ruszniewski,
D. Le Guludec,
M. Mignon
|
7 |
1996 |
7
🐜
|
|
🐜
|
Radiolabeled Fucoidan as a P-Selectin Targeting Agent for In Vivo Imaging of Platelet-Rich Thrombus and Endothelial Activation
12 auth.
F. Rouzet,
Laure Bachelet-Violette,
J. Alsac,
Michimasa Suzuki,
A. Meulemans,
L. Louedec,
...
A. Petiet,
M. Jandrot-Perrus,
F. Chaubet,
J. Michel,
D. Le Guludec,
D. Letourneur
|
6 |
2011 |
6
🐜
|
|
🐬
|
Variability and Uncertainty of 18F-FDG PET Imaging Protocols for Assessing Inflammation in Atherosclerosis: Suggestions for Improvement
P. Huet,
S. Burg,
D. Le Guludec,
F. Hyafil,
I. Buvat
|
6 |
2015 |
6
🐬
|
|
🐢
|
Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography.
12 auth.
F. Hyafil,
F. Rouzet,
L. Lepage,
K. Benali,
R. Raffoul,
X. Duval,
...
U. Hvass,
B. Iung,
P. Nataf,
R. Lebtahi,
A. Vahanian,
D. Le Guludec
|
6 |
2013 |
6
🐢
|
|
🐜
|
Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease.
14 auth.
J. Knuuti,
F. Bengel,
Jeroen J. Bax,
P. Kaufmann,
D. Le Guludec,
Pasquale Perrone Filardi,
C. Marcassa,
N. Ajmone Marsan,
S. Achenbach,
A. Kitsiou,
...
A. Flotats,
É. Eeckhout,
H. Minn,
B. Hesse
|
6 |
2014 |
6
🐜
|
|
🐢
|
Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
9 auth.
R. Lebtahi,
J. Le Cloirec,
C. Houzard,
D. Daou,
I. Sobhani,
G. Sassolas,
...
M. Mignon,
P. Bourguet,
D. Le Guludec
|
6 |
2002 |
6
🐢
|
|
🐜
|
Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study.
21 auth.
R. Senior,
A. Moreo,
N. Gaibazzi,
L. Agati,
K. Tiemann,
B. Shivalkar,
S. von Bardeleben,
L. Galiuto,
H. Lardoux,
G. Trocino,
...
I. Carrió,
D. Le Guludec,
G. Sambuceti,
H. Becher,
P. Colonna,
F. T. ten Cate,
E. Bramucci,
A. Cohen,
G. Bezante,
C. Aggeli,
J. Kasprzak
|
6 |
2013 |
6
🐜
|
